Synthesis and Antibacterial Activity of Novel Phosphonated CF₃-β-lactams

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antimicrobial Research

Background:

• Fluorinated β-lactams are valuable scaffolds in drug discovery.
• Phosphonate groups can enhance pharmacokinetic properties and biological activity.
• The emergence of antibiotic resistance necessitates novel antibacterial agents.

Purpose of the Study:

• To stereoselectively synthesize novel C-3 phosphonated 4-CF3-β-lactams.
• To evaluate the antibacterial activity of these compounds against clinically relevant bacterial strains.
• To identify lead compounds for further development as antibiotics.

Main Methods:

• Stereoselective synthesis of C-3 phosphonated 4-CF3-β-lactams via two distinct phosphonate incorporation strategies.
• Evaluation of antibacterial activity using disk diffusion and minimum inhibitory concentration (MIC) assays.
• Assessment of β-lactamase inhibition potential.

Main Results:

• Successful synthesis of C-3 phosphonated 4-CF3-β-lactams, with a phosphonite intermediate strategy overcoming steric hindrance.
• Compounds 11 and 16 demonstrated significant antibacterial activity against Staphylococcus aureus, MRSA, Neisseria gonorrheae, and Escherichia coli.
• Preliminary data suggests potential for β-lactamase inhibition.

Conclusions:

• The synthesized C-3 phosphonated 4-CF3-β-lactams represent a promising new class of potential antibacterial agents.
• Compounds 11 and 16 are identified as lead candidates warranting further investigation.
• The incorporation of fluorinated and phosphonate moieties is a viable strategy for developing novel antimicrobials.